Home › Leucemia mieloide acuta › Distretto di Columbia › Washington
Studi clinici su Leucemia mieloide acuta a Washington, DC
24 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
In reclutamentoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- Center for Cancer and Blood Disorders, Bethesda · a 7 mi di distanza
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
In reclutamentoFase 2
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- MedStar Georgetown University Hospital, Washington D.C.
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Longitudinal Studies of Patient With FPDMM
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 1/2Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
In reclutamentoStudio osservazionale
- The Center for Cancer and Blood Disorders, Bethesda · a 7 mi di distanza
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- Children's National Medical Center, Washington D.C.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- Children's National - Main Hospital, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
In reclutamentoFase 1
- Childrens National Medical Center, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · a 7 mi di distanza
- Nih/Nhlbi, Bethesda · a 7 mi di distanza
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
In reclutamentoFase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · a 7 mi di distanza
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Cancer Support Community Research & Training Institute, Washington D.C.
Massage Impact on Sleep in Pediatric Oncology
In reclutamento
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
In reclutamentoFase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Phase IB/II of CPX-351 for Relapse Prevention in AML
In reclutamentoFase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Cancro alla prostata38 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Cancro ovarico23 studi
- Linfoma23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.